Publications by authors named "Neslihan Kayahan"

Claim this Profile
F
Folfirinox versus gemcitabine-cisplatin combination as first-line therapy in treatment of pancreaticobiliary cancer.
Neslihan Kayahan, Mustafa Karaca, Hasan Satış, Dilek Yapar, Ahmet Özet

Turk J Med Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation and course of the novel coronavirus disease 2019 in patients with various types of cancer: A retrospective case-control analysis of an experienced cancer center in Turkey.
Ramazan Acar, Gulden Yilmaz, Umit Savasci, Musa Baris Aykan, Halil Kiziloz, Neslihan Kayahan

J Cancer Res Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Inpatient epidemiology and economic burden of granulomatosis with polyangiitis: a 10-year study of the national inpatient sample.
Hasan Satış, Neslihan Kayahan, Hakan Babaoğlu, Orhun Akdoğan, Dilek Yapar

Rheumatology (Oxford)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero.
Hasan Satış, Reyhan Bilici Salman, Aslihan Avanoğlu Güler, Hazan Karadeniz, Şeyma Yıldız, Neslihan Kayahan

Ann Rheum Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.
Hasan Satış, Ahmet Oruç, Ayla Avcu, Hazan Karadeniz, Aslıhan Avanoğlu Güler, Neslihan Kayahan

Rheumatology (Oxford)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit?
Hasan Satış, Alper Şenkalfa, Hazan Karadeniz, Aslıhan Avanoğlu, Reyhan Bilici Salman, Neslihan Kayahan

Rheumatology (Oxford)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis